Iris Unipi Prodmetadata only
Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion
angiocrine factor, diabete, gliflozine, myocardial ischemia-reperfusion injury, oxidative stress
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 224617
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.